AroCell AB (publ.) announced that Peter Löwendahl joins the management team as senior director regulatory affairs. Peter Löwendahl will lead and develop AroCell's regulatory strategy with focus on the US market and FDA clearance of TK 210 ELISA. Peter Löwendahl has almost 30 years of experience in quality and regulatory affairs and has previously been responsible for Quality and Regulatory affairs at Elekta AB and global egulatory responsibility for GE Healthcare's Life science division.